Hear from us 18 April 2024 Orphelia Pharma secures European patent covering KIGABEQ®, the first pediatric formulation of vigabatrin Read More > 5 March 2024 International Drug Repurposing Conference 2024, 6-7th March 2024, Barcelona Read More > 15 February 2024 ORPHELIA Pharma raises awareness for childhood cancer Read More > 9 January 2024 ORPHELIA Pharma announces the publication of two scientific articles on KIZFIZO, the first pediatric drinkable formulation of temozolomide for the treatment of refractory or relapsed neuroblastoma Read More > 29 November 2023 Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide Read More > 28 November 2023 ORPHELIA Pharma to support the European paediatric Soft Tissue Sarcoma Study Group winter meeting. Read More >